Mickaël Coelho

Title: Mickaël Coelho: Innovator in Cancer Immunotherapy

Introduction

Mickaël Coelho is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cancer immunotherapy, particularly through his innovative work on antibody fragments.

Latest Patents

Mickaël Coelho holds a patent for "Human anti-idiotypic antibody fragments that mimic HER-2/neu." This invention relates to human anti-idiotypic antibody fragments, especially scFv, characterized by the ability to mimic the Her-2/neu tumor-associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients who are positive for Her-2/neu. He has 1 patent to his name.

Career Highlights

Throughout his career, Mickaël has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre Régional de Lutte Contre Le Cancer “Val D'Aurelle-Paul Lamarque.” His work in these organizations has contributed to advancements in medical research and cancer treatment.

Collaborations

Mickaël has collaborated with notable professionals in his field, including Philippe Gauthier and André Pelegrin. These collaborations have further enhanced his research and development efforts in cancer immunotherapy.

Conclusion

Mickaël Coelho is a pioneering inventor whose work in developing antibody fragments for cancer treatment holds great promise for the future of immunotherapy. His contributions to the field are invaluable and continue to inspire advancements in medical science.